Skip to main content

There are many complexities that make cell and gene therapy development challenging. It is crucial the new gene reaches the correct cell without causing an unintended immune response.

Introducing PanCancerIQ

Our new next-generation sequencing (NGS) assay that enables comprehensive genomic profiling of solid tumor samples. Another powerful addition to the Eurofins Viracor Biopharma portfolio supporting precision oncology studies. 

Learn More

Back to top